Loading...
Everolimus — Export Intelligence Report
2025-Q4 · TransData Nexus
PHARMA TRADE INTELLIGENCE
INDIA EXPORT INTELLIGENCE REPORT
Everolimus
2025-Q4
Comprehensive analysis of India’s everolimus export trade — suppliers, buyers, prices, routes, and every shipment record.
61
Shipments
$2.70M
Trade Value
23
Suppliers
22
Buyers
20
Countries
Scan for online report
Talk to our analyst: +91 95950 78788
https://transdatanexus.com/pharmaceutical/everolimus
01
PART I — OVERVIEW
Executive Summary
At-a-glance KPIs, key findings, and strategic positioning of India’s everolimus trade — 2025-Q4
KEY TAKEAWAY
Everolimus 2025-Q4 exports total $2.7M across 20 countries, with ALKEM LABORATORIES LTD commanding 57.7% market share.
TOTAL SHIPMENTS
61
2025-Q4
EXPORT VALUE
$2.7M
FOB USD
TOTAL QUANTITY
227.8K
units shipped
INDIAN SUPPLIERS
23
unique exporters
GLOBAL BUYERS
22
unique importers
DESTINATIONS
20
countries
MEDIAN UNIT PRICE
$33.90
per unit
TOP-5 SHARE
99.1%
of total USD
BRANDED SHARE
62.3%
38 shipments
DOSAGE FORMS
2
product types
6 KEY FINDINGS
1
ALKEM LABORATORIES LTD is India's #1 Everolimus exporter with $1.6M (57.7% market share).→ §5, Indian Supplier Rankings
2
Everolimus reached 20 countries, with United States as the top destination ($2.1M).→ §4, Global Destination Map
3
Market concentration is high (HHI: 4227) — top 10 suppliers control 99.8% of exports.→ §5, Indian Supplier Rankings
4
90.9% of buyers (20 of 22) source from a single Indian supplier — potential poaching opportunities.→ §6, Global Buyer Rankings
5
Tablet dominates (99.9%) across 2 dosage forms.→ §7, Price Benchmarks
6
20 countries have ≤5 Indian suppliers — easy-entry markets for SME exporters.→ §9, Strategic Opportunities
WHO THIS REPORT IS FOR
S SUPPLIERS (Indian pharma exporters)
- See which buyers your competitors are shipping to, at what price, through which ports
- Identify buyers that are single-sourced (poaching opportunities)
- Benchmark your pricing and catalog vs the Top 25
B BUYERS (global importers)
- Discover which Indian exporters supply this product and what they sell
- Benchmark the price you are paying vs the market median by country and dosage
- Identify alternative suppliers with proven exports to similar destinations
Figure 1.1 ALKEM LABORATORIES LTD leads in volume — how do 23 exporters compare on price × volume?
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Every bubble is one Indian everolimus exporter. X-axis = shipment count; Y-axis = average unit price; bubble size = total revenue. Dashed lines split at the median — exporters in the top-right (Bulk Leaders) combine high volume with premium pricing.
HOW TO READ THIS REPORT
60 seconds
Scan this page — KPIs, thesis, flagship chart, top findings
5 minutes
Read every Key Takeaway line across §1–§9
30 minutes
Read sections tagged for your role ([S] or [B]) end-to-end
In depth
Drill into §10 for your country · supplier / buyer directories at end
02
PART I — OVERVIEW
About This Report
Data sources, methodology, trust signals, and what this Everolimus report covers
KEY TAKEAWAY
Every figure in this report is grounded in real commercial everolimus trade records. Data comes from official customs filings and public trade sources, runs through a multi-layer quality process, and lands in a clean, consistent report you can rely on.
S FOR SUPPLIERS
Every competitor benchmark, market share figure, and buyer list in this report comes from verified commercial shipments — not surveys or estimates. Use them with confidence when planning your next pitch.
B FOR BUYERS
Every supplier profile, price benchmark, and trade route in this report reflects what that supplier actually ships — real volumes, real destinations, real prices. Use them to qualify and compare Indian everolimus suppliers.
§2.1 Reporting parameters · the scope of this 2025-Q4 Everolimus India trade report
Product scope
Everolimus
All variants merged — branded and generic formulations of everolimus
Time period
2025-Q4
October, November, December 2025 — a single-quarter snapshot
Data sources
Official & public trade records
Government customs filings, public trade databases and licensed commercial feeds
Geography
India origin → global
Indian sea and air ports shipping to destination markets worldwide
Currency
USD (FOB)
Declared Free-on-Board value at the Indian port of loading
Shipments analysed
61
Every commercial everolimus trade record in the period, aggregated and deduplicated
§2.2 Our quality process · Figure 2.1
Figure 2.1 From raw trade records to a clean report — the four quality pillars.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Raw trade data (left) flows through four quality checks — source verification, format standardisation, entity matching, and deduplication — to produce the clean, reliable data (right) behind every chart and table in this report.
§2.3 Trust signals · what you can rely on in the numbers you read
DATA COVERAGE
10M+
Pharmaceutical trade records across the full TransData Nexus platform.
COUNTRIES
150+
Origin and destination countries covered in the global pharma trade database.
DATA ACCURACY
99.9%
Validation rate on core fields — supplier, buyer, product, quantity, value.
UPDATE FREQUENCY
Daily
Platform refresh cadence. This report is a snapshot from the same live data.
§2.4 Limitations · what the data does and does not tell you
WHAT THIS DATA DOES AND DOES NOT SAY
- Prices are at the Indian port of loading (FOB), not the final delivered cost in the destination country. Freight, insurance, import duty and local margin are not included.
- This is a single-quarter snapshot. Multi-quarter trends, year-over-year growth and historical comparisons are available on the full platform.
- A small number of records have incomplete transport mode or destination port fields; these appear blank in the shipment register but are still counted in totals.
- This report is a commercial intelligence tool, not a legal audit. For high-stakes decisions, cross-reference with the underlying trade records via the full platform.
03
PART II — MARKET STRUCTURE
Quarterly Trade Overview
Monthly trends, regional performance, and ranking shifts — 2025-Q4
KEY TAKEAWAY
2025-Q4 followed a mixed: Oct $1.5M, Nov $623.6K, Dec $597.7K. Shipment counts rose across the quarter.
S FOR SUPPLIERS
Track which months your competitors were most active, which destinations rose or fell, and whether the Nov dip hit your segment. The bump charts show rank movement — watch for rivals climbing past you.
B FOR BUYERS
Identify whether your current Indian supplier maintained steady shipments through the quarter, or whether they pulled back. Steady suppliers during dips signal reliable partnerships.
1
$1.5M
Oct USD
19 shipments
2
$623.6K
Nov USD
-57.8% MoM
3
$597.7K
Dec USD
-4.1% MoM
4
Mixed
Q4 growth shape
Oct → Nov → Dec
Fig 3.1 Nov dipped 57.8% in USD but shipment count kept steady.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Blue bars = monthly USD. Orange line = shipment count. When bars drop but line rises, average shipment value fell. Insight: Oct opened at $1.5M, making it the strongest month by value.
Fig 3.2 Q4 cumulative USD reached $2.7M.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: The curve shows the running total across the quarter. A steeper slope means that month contributed more revenue. Insight: The curve’s steepest section reveals which month drove the most trade value.
Fig 3.3 $856K dip in Nov, $26K decline in Dec.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Blue bars = absolute monthly value. Red = month-over-month loss; green = gain. Insight: Nov’s dip was fully recovered by Dec.
Fig 3.4 Regional breakdown by month — which corridors swung most?
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each coloured layer is one destination region. Layer height = USD in that month. Insight: The top region contributed the most, while the smallest region had the least volume.
§3.1 Monthly summary
| Oct | $1.5M | 19 shipments |
| Nov | $624K | 11 shipments |
| Dec | $598K | 31 shipments |
| Q4 Total | $2.7M | 61 shipments |
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
Fig 3.5 Top 10 destination countries by monthly USD rank — who’s rising?
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each line traces a country’s monthly rank. Lines crossing = rank swaps. Insight: United States held #1 throughout the quarter.
Fig 3.6 Top 10 Indian exporters by monthly USD rank.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each line traces a supplier’s monthly rank. Flat = stable position; crossing = rank change. Insight: ALKEM LABORATORIES LTD maintained its leading position.
04
PART II — MARKET STRUCTURE
Global Destination Map
Which countries import everolimus from India, how much they buy, and who supplies each market
KEY TAKEAWAY
United States absorbs 77.1% of India’s 2025-Q4 everolimus trade ($2.1M). Beyond the top 10 destinations, 20 countries have fewer than 5 Indian suppliers each — white-space markets where new entrants face minimal competition. Asia has 9 destination countries, the widest regional diversity.
S FOR SUPPLIERS
Use the flow map and lanes table to see which destinations your competitors dominate. For small and mid-size suppliers: look beyond the leading markets — the 20 countries in the long tail have fewer than 5 Indian suppliers each and low competitive barriers.
B FOR BUYERS
Find your country on the map to see how much everolimus India ships to your market, who the top suppliers are, and whether you’re in a concentrated or competitive corridor.
Asia
$61K
2.3% of trade
9 countries · 20 shipments
Europe
$478K
17.7% of trade
1 countries · 3 shipments
Americas
$2.2M
79.8% of trade
5 countries · 28 shipments
Africa
$6K
0.2% of trade
5 countries · 10 shipments
Fig 4.1 United States is the #1 corridor ($2.1M) — 20 flow arcs from India radiate across 4 continents.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: The world map shows every country colored by how much Indian everolimus it receives (light = low, dark = high). Orange arcs radiate from India to the top 20 destinations; arc thickness = USD value. All destinations are labeled with country name + USD.
§4.1 Top 10 bilateral trade lanes (India → destination) with top Indian suppliers
| # | Destination | Total USD | Ships | #1 Indian supplier | USD | #2 Indian supplier | USD | #3 Indian supplier | USD |
|---|---|---|---|---|---|---|---|---|---|
| 1 | United States | $2.1M | 21 | ALKEM LABORATORIES LTD | $1.6M | PAR FORMULATIONS PVT LTD | $336K | NATCO PHARMA LTD | $186K |
| 2 | Malta | $478K | 3 | NATCO PHARMA LTD | $478K | — | — | — | — |
| 3 | Canada | $72K | 3 | NATCO PHARMA LTD | $72K | — | — | — | — |
| 4 | Lebanon | $37K | 2 | GLOBELA PHARMA PVT LTD | $34K | RMPL PHARMA LLP | $3K | — | — |
| 5 | Saudi Arabia | $11K | 1 | ASPIRO PHARMA LTD | $11K | — | — | — | — |
| 6 | Nepal | $8K | 2 | BDR PHARMACEUTICALS INTERNATIONAL PVT LTD | $8K | — | — | — | — |
| 7 | Kenya | $5K | 5 | R.S. SURGIPHARM PVT LTD | $4K | 3S CORP | $461 | — | — |
| 8 | Iraq | $2K | 3 | VATS INDUSTRIES PVT LTD | $2K | — | — | — | — |
| 9 | Maldives | $1K | 5 | NU HOSPITALS PVT LTD | $1K | MC PHARMA DISTRIBUTORS | $3 | — | — |
| 10 | Uganda | $1K | 2 | BDR PHARMACEUTICALS INTERNATIONAL PVT LTD | $1K | — | — | — | — |
Table 4.1 — Top 10 destination countries ranked by trade value, with the largest Indian suppliers for each market.
Fig 4.2 Asia leads at 2.3% of USD — but United States is the single largest market.
Region → country treemap
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Column width = region USD share. Within each column, cells are stacked by country, height = share within region.
§4.2 Destination concentration
77.1%
#1 country share
United States alone
99.2%
Top 5 share
5 of 20 countries
100.0%
Top 15 share
Long tail of 5 countries = 0.0%
HHI 6260
Destination HHI
Highly concentrated
20
Countries served
Global pharma reach from India
9
Asia countries
Widest regional diversity
Source: TransData Nexus trade data platform
05
PART III — WHO’S IN THIS MARKET
Indian Supplier Rankings & Profiles
23 Indian exporters ranked by value — profiles, portfolios, and competitive intelligence
KEY TAKEAWAY
ALKEM LABORATORIES LTD ($1.6M, 57.7% share) and NATCO PHARMA LTD ($736.8K) together control 85.0% of India’s 2025-Q4 everolimus trade. The top 5 suppliers hold 99.1%. 23 companies shipped at least once.
S FOR SUPPLIERS
Find your rank, your competitors’ ranks, and the gap in USD/share between you. The profile pages show each top supplier’s buyer portfolio, dosage mix and route map — your competitive-intelligence toolkit.
B FOR BUYERS
Find potential Indian everolimus suppliers ranked by size, catalog breadth and destination reach. The profile pages reveal which suppliers have proven trade lanes to your region.
Fig 5.1 ALKEM LABORATORIES LTD leads by $821K over NATCO PHARMA LTD — top 20 Indian exporters ranked by trade value
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each bar = one Indian supplier ranked by USD. The (#N) shows their rank by shipment count — mismatches reveal pricing strategy. Insight: GLOBELA PHARMA PVT is #4 by value but #12 by volume.
Fig 5.2 ALKEM LABORATORIES LTD also leads by shipment count (10) but ranking shifts for volume-heavy players
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Same suppliers re-ranked by shipment count. The (#N) shows their rank by USD value. Insight: GLOBELA PHARMA PVT moves from #12 by volume to #4 by value — fewer but higher-value shipments.
05
PART III — WHO’S IN THIS MARKET
Supply Landscape — Archetypes & Concentration
How India’s 23 everolimus suppliers split into strategic segments
KEY TAKEAWAY
6 suppliers (25%) generate 99.4% of total trade value. The market splits into four archetypes: Market Leaders, High-Value specialists, Volume players, and a long tail.
Fig 5.3 ALKEM LABORATORIES LTD and NATCO PHARMA LTD sit in the leaders zone — high volume AND high value.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each bubble is one Indian supplier. X-axis = shipment count (log scale); Y-axis = total USD value (log scale); bubble size = revenue. Blue dashed lines split at the median. Market Leaders (top-right) combine high volume with high value. Premium Niche (top-left) ship fewer but higher-value consignments. Volume Players (bottom-right) compete on quantity. Long-Tail (bottom-left) are small or occasional exporters. Conclusion: the log scale reveals clear strategic clusters — use this map to identify where your company sits relative to competitors.
Fig 5.4 25% of suppliers = 99.4% of USD — classic concentration.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Top bar = supplier %, bottom bar = USD %. The gap = market concentration.
Product variety — how many formulations each supplier ships
| # | Supplier | Dosage forms | Countries | USD |
|---|---|---|---|---|
| 1 | ALKEM LABORATORIES LTD | 1 | 1 | $1.6M |
| 2 | NATCO PHARMA LTD | 1 | 3 | $737K |
| 3 | PAR FORMULATIONS PVT LTD | 1 | 1 | $336K |
| 4 | GLOBELA PHARMA PVT LTD | 1 | 1 | $34K |
| 5 | ASPIRO PHARMA LTD | 1 | 1 | $11K |
| 6 | BDR PHARMACEUTICALS INTERNATIONAL PVT LTD | 1 | 2 | $9K |
| 7 | R.S. SURGIPHARM PVT LTD | 1 | 1 | $4K |
| 8 | RMPL PHARMA LLP | 1 | 3 | $3K |
| 9 | VATS INDUSTRIES PVT LTD | 1 | 1 | $2K |
| 10 | NU HOSPITALS PVT LTD | 1 | 1 | $1K |
Table 5.1 — The more dosage forms a supplier ships, the more versatile their manufacturing capability.
05
PART III — WHO’S IN THIS MARKET
Supply Landscape — India Origin Geography & Concentration
Which Indian cities and states are the everolimus manufacturing hubs
KEY TAKEAWAY
Hyderabad and Panvel together account for $1.2M of India’s 2025-Q4 everolimus trade.
Fig 5.5 Hyderabad (1 exporters, $737K) and Panvel (1 exporters, $483K) are India’s everolimus capitals.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Orange bubbles mark major pharma hub cities; bubble size = USD value. Every hub labeled.
§5.1 Supplier concentration metrics
99.1%
Top 5 share
5 of 23 suppliers
99.8%
Top 10 share
10 of 23 suppliers
99.4%
Top 25% share
6 suppliers = 99% USD
HHI 4227
Supplier HHI
Concentrated
23
Total suppliers
shipped Everolimus in 2025-Q4
15+ cities
Indian hubs
Hyderabad and Panvel lead
§5.2 Coming next: 1 exporter deep-dive profiles
Each of the top 1 suppliers gets a dedicated 2-page profile with:
- 6 KPI cards — trade value, shipments, countries, buyers, avg ship value, branded share
- Dosage form breakdown — what formulations they ship
- Monthly trend — Oct / Nov / Dec trajectory
- Trade flow map — supplier → country → importer connections
- Buyer portfolio with lock-in analysis
SUPPLIER PROFILES IN THIS REPORT
| #1 | NATCO PHARMA LTD | $737K |
#2
EXPORTER PROFILE #1 OF 1
NATCO PHARMA LTD
Hyderabad · India’s #2 everolimus supplier by USD · 2025-Q4
2025-Q4 USD
$737K
27.3% market share
SHIPMENTS
9
avg $82K/ship
COUNTRIES
3
destination markets
BUYERS
3
3 single-sourced
BRANDED
67%
of shipments
DOSAGE FORMS
1
product types
TOP 3 DESTINATIONS
Malta is the #1 market at $478K (65% of trade), followed by United States at $186K. 3 countries served.
| # | Country | USD | Ships | Share |
|---|---|---|---|---|
| 1 | Malta | $478K | 3 | 64.9% |
| 2 | United States | $186K | 3 | 25.3% |
| 3 | Canada | $72K | 3 | 9.8% |
MONTHLY TREND
Oct peaked at $737K. Nov was the weakest at $0.
PRODUCT MIX
Tablet dominates at 100% of trade.
TOP BUYERS · 3/3 LOCKED IN
3 of 3 buyers source exclusively from this supplier — high lock-in with low competitive threat.
| Buyer | Country | USD | Status |
|---|---|---|---|
| PHARMACARE PREMIUM | Malta | $478K | ⚠ Locked |
| BRECKENRIDGE PHARMACEU… | United States | $186K | ⚠ Locked |
| NATCO PHARMA (CANADA) … | Canada | $72K | ⚠ Locked |
#2
EXPORTER PROFILE #1 OF 1 — TRADE FLOW MAP
NATCO PHARMA LTD — Supplier → Country → Importer
3 destination countries, top 5 importers per country
Fig 5.P1.3 Malta absorbs $478K — the thickest ribbon.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Left = Indian supplier. Middle = destination countries (ordered by USD). Right = importers within each country. Ribbon thickness = USD value; color = country. Every node labeled with name + USD + ships. Showing top 3 destinations and up to 1 importers per destination.
06
PART III — WHO’S IN THIS MARKET
Global Buyer Rankings & Intelligence
22 importers across 20 countries — who is buying Indian everolimus and how much
KEY TAKEAWAY
The demand side is dramatically more fragmented than supply: the top 20 importers together hold only 87.9% of total USD. 91% of buyers source from a single Indian supplier — a vast pool of lock-in candidates.
S FOR SUPPLIERS
Find the importers buying from your competitors. The rankings reveal who has volume, who pays well, and who sources from multiple Indian suppliers (potential pitch targets).
B FOR BUYERS
See where you rank among global importers of Indian everolimus. Compare your USD and shipment count against peers in your country and dosage segment.
Fig 6.1 ASCEND LABORATORIES LLC is the #1 importer at $1.3M (47.1%) — top 20 by trade value
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each bar = one global importer ranked by USD.
Fig 6.2 Re-ranked by shipment count — compare with Fig 6.1 for divergences
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Same 20 importers re-ranked by shipment count.
§6.1 Sourcing diversity — how many Indian suppliers does each buyer use?
91%
Single-source
20 buyers rely on exactly 1 Indian supplier
5%
Dual-source
1 buyers use 2 Indian suppliers
0%
Multi-source (3–4)
0 buyers diversified across 3–4
5%
Broad-source (5+)
1 buyers with 5+ Indian suppliers
06
PART III — WHO’S IN THIS MARKET
Single-Source Buyers & Price Benchmark
Lock-in opportunities grouped by country + where each buyer sits on the price spectrum
KEY TAKEAWAY
These importers source everolimus from exactly one Indian supplier. For each one, the table shows the incumbent, price, and dosage.
S FOR SUPPLIERS
This is your target list. Each row is a buyer locked into one competitor. Offer 5–10% better pricing to win the second-source slot.
B FOR BUYERS
If you see your company here, you are fully dependent on one Indian supplier. Consider qualifying a second source.
§6.2 Single-source lock-in by country
United States 5 single-source buyers
| Importer | Current supplier | USD | Unit $ | Dosage |
|---|---|---|---|---|
| ASCEND LABORATORIES LLC | ALKEM LABORATORIES LTD | $1.3M | $59.075 | Tablet |
| UPS SUPPLY CHAIN SOLUT… | PAR FORMULATIONS PVT… | $279K | $25.483 | Tablet |
| BRECKENRIDGE PHARMACEU… | NATCO PHARMA LTD | $186K | $2.936 | Tablet |
| UPS SUPPLY CHAIN SOLUT… | PAR FORMULATIONS PVT… | $56K | $33.897 | Tablet |
| UNITED AMERICA GROUP LLC | ALLMPUS LABORATORIES… | $1K | $663.923 | Injection |
Maldives 2 single-source buyers
| Importer | Current supplier | USD | Unit $ | Dosage |
|---|---|---|---|---|
| INDIRA GANDHI MEMOROAL… | NU HOSPITALS PVT LTD | $1K | $1.160 | Tablet |
| STATE TRADING ORGANIZA… | MC PHARMA DISTRIBUTORS | $3.127 | $0.0087 | Tablet |
Malta 1 single-source buyers
| Importer | Current supplier | USD | Unit $ | Dosage |
|---|---|---|---|---|
| PHARMACARE PREMIUM | NATCO PHARMA LTD | $478K | $5.356 | Tablet |
Canada 1 single-source buyers
| Importer | Current supplier | USD | Unit $ | Dosage |
|---|---|---|---|---|
| NATCO PHARMA (CANADA) … | NATCO PHARMA LTD | $72K | $2.747 | Tablet |
Saudi Arabia 1 single-source buyers
| Importer | Current supplier | USD | Unit $ | Dosage |
|---|---|---|---|---|
| SAUDI AMAROX FOR INDUS… | ASPIRO PHARMA LTD | $11K | $2.266 | Tablet |
§6.3 Price positioning — top 20 importers
| # | Importer | Country | USD | $/ship | Tier |
|---|---|---|---|---|---|
| 1 | ASCEND LABORATORIES … | United States | $1.3M | $159K | Premium |
| 2 | PHARMACARE PREMIUM | Malta | $478K | $159K | Premium |
| 3 | UPS SUPPLY CHAIN SOL… | United States | $279K | $56K | Premium |
| 4 | BRECKENRIDGE PHARMAC… | United States | $186K | $62K | Premium |
| 5 | NATCO PHARMA (CANADA… | Canada | $72K | $24K | Mid |
| 6 | UPS SUPPLY CHAIN SOL… | United States | $56K | $56K | Premium |
| 7 | SAUDI AMAROX FOR IND… | Saudi Arabia | $11K | $11K | Budget |
| 8 | AM BIOTECH PVT LTD | Nepal | $8K | $4K | Budget |
| 9 | ATLAS TRADING COMPANY | Iraq | $2K | $605.000 | Budget |
| 10 | INDIRA GANDHI MEMORO… | Maldives | $1K | $365.000 | Budget |
| 11 | ONLT | Uganda | $1K | $711.000 | Budget |
| 12 | UNITED AMERICA GROUP… | United States | $1K | $664.000 | Budget |
| 13 | ZMC EXPRESS CARGO FZCO | United Arab Emirates | $870.181 | $435.000 | Budget |
| 14 | MR VONMUNA | Laos | $845.467 | $845.000 | Budget |
| 15 | THE PURCHASE MANAGER | Chile | $744.465 | $372.000 | Budget |
| 16 | FOR .THE ORDER OF | Kenya | $461.359 | $461.000 | Budget |
| 17 | ABU ABDU | Turkey | $9.415 | $9.000 | Budget |
| 18 | STATE TRADING ORGANI… | Maldives | $3.127 | $3.000 | Budget |
| 19 | NAME : AYGUN | Azerbaijan | $1.442 | $1.000 | Budget |
| 20 | AL KHALLEJ LAND HOLD… | United Arab Emirates | $0.0000 | $0.0000 | Budget |
06
PART III — WHO’S IN THIS MARKET
Market Relationship Map
The top 20 × 20 supplier ↔ buyer network as a circular flow diagram
Fig 6.3 ALKEM LABORATORIES LTD → ASCEND LABORATORIES LLC is the strongest relationship.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Left semicircle = top 20 Indian suppliers; right = top 20 global buyers. Arc length = total USD; colored ribbons = individual relationships, thickness = USD value. Insight: follow the thickest ribbons to identify the dominant trading pairs.
07
PART IV — MARKET BEHAVIOR
Price Benchmarks & Analysis
How Indian everolimus prices vary by supplier, country and dosage form
KEY TAKEAWAY
Everolimus prices span 742410× ($0.0016 → $1150.78). The coefficient of variation is 2.83. Dosage form, not destination, is the primary price driver.
S FOR SUPPLIERS
Use the box plot to see where your product sits on the price spectrum. The tornado chart shows exactly where you sit relative to the market median.
B FOR BUYERS
Use this section to benchmark the price you pay against the market. The percentile strip tells you if your current supplier is charging you premium, mid-market or budget rates.
§7.1 Price distribution · Table 7.1
| Statistic | Value | Interpretation |
|---|---|---|
| Min | $0.0016 | Lowest observed unit price |
| P5 | $0.018 | 5th percentile |
| P25 | $1.62 | 25th percentile (Q1) |
| Median | $33.90 | 50th percentile (Q2) |
| P75 | $49.92 | 75th percentile (Q3) |
| P95 | $105.91 | 95th percentile |
| Max | $1.2K | Highest observed unit price |
| Mean | $52.14 | Arithmetic average |
| CV | 283% | Coefficient of variation (std/mean) |
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
Fig 7.1 ALLMPUS LABORATORIES PVT LTD prices at $663.92/unit vs market median $33.90.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each bar shows one supplier’s average unit price relative to the market median (dashed line). Red = above median (premium), green = below (budget).
COMMODITY KINGS
high volume · low unit price
Bulk API/tablet. Largest absolute USD despite lowest per-unit prices. e.g. NATCO PHARMA LTD Sourcing: best for cost-driven procurement.
BULK LEADERS
high volume · premium price
Branded-generic leaders, above-median pricing. e.g. ALKEM LABORATORIES LTD Sourcing: hardest to displace; compete on relationship.
LONG-TAIL
low volume · low unit price
Spot/opportunistic players. e.g. ASPIRO PHARMA LTD Sourcing: first to approach for new tenders.
PREMIUM NICHE
low volume · premium price
Sterile injectables and infusions. Hospital-grade. e.g. GLOBELA PHARMA PVT Sourcing: expect 10× price vs tablet.
07
PART IV — MARKET BEHAVIOR
Price Benchmarks & Analysis
Outlier forensics and the procurement cheat sheet — what to expect to pay by country × dosage
KEY TAKEAWAY
Extreme prices are real: the highest are specialty/sterile formulations; the lowest are bulk API. The cheat sheet matrix is the take-home reference for procurement teams.
§7.2 Outlier forensics — top 10 highest and 10 lowest unit prices
↑ TOP 10 HIGHEST USD/UNIT
| Date | Exporter | Country | Dosage | Qty | USD | $/unit | Why |
|---|---|---|---|---|---|---|---|
| Dec 2025 | ALLMPUS LABORATO… | United States | Injection | 1 | $1K | $1K | Sterile formulation premium |
| Dec 2025 | ALLMPUS LABORATO… | United States | Injection | 1 | $177.06 | $177.06 | Sterile formulation premium |
| Dec 2025 | MEDINEX HEALTHCARE | Mexico | Tablet | 5 | $713.90 | $142.78 | Specialty / small-batch |
| Nov 2025 | ALKEM LABORATORI… | United States | Tablet | 1K | $115K | $103.97 | Specialty / small-batch |
| Dec 2025 | ALKEM LABORATORI… | United States | Tablet | 2K | $232K | $102.97 | Specialty / small-batch |
| Dec 2025 | GLOBELA PHARMA P… | Lebanon | Tablet | 334 | $34K | $102.00 | Specialty / small-batch |
| Dec 2025 | YARAPMIN PHARMA … | Brazil | — | 6 | $423.27 | $70.55 | Specialty / small-batch |
| Nov 2025 | BDR PHARMACEUTIC… | Uganda | Tablet | 20 | $1K | $70.32 | Specialty / small-batch |
| Dec 2025 | ALKEM LABORATORI… | United States | Tablet | 2K | $152K | $69.30 | Specialty / small-batch |
| Oct 2025 | ALKEM LABORATORI… | United States | Tablet | 2K | $143K | $67.55 | Specialty / small-batch |
↓ TOP 10 LOWEST USD/UNIT
| Date | Exporter | Country | Dosage | Qty | USD | $/unit | Why |
|---|---|---|---|---|---|---|---|
| Dec 2025 | CHOUDHARI IMPEX | Seychelles | Tablet | 2K | $3.24 | $0.0016 | Bulk generic tablet |
| Dec 2025 | MC PHARMA DISTRI… | Maldives | Tablet | 360 | $3.13 | $0.0087 | Bulk generic tablet |
| Dec 2025 | NU HOSPITALS PVT… | Maldives | Tablet | 60 | $1.11 | $0.018 | Small sample / trial shipment |
| Dec 2025 | NU HOSPITALS PVT… | Maldives | Tablet | 300 | $5.53 | $0.018 | Small sample / trial shipment |
| Dec 2025 | RMPL PHARMA LLP | Tanzania | Tablet | 200 | $7.02 | $0.035 | Small sample / trial shipment |
| Dec 2025 | KALINDI OVERSEAS | Chile | Tablet | 72 | $14.35 | $0.199 | Small sample / trial shipment |
| Dec 2025 | BRUCK PHARMA PVT… | Cote d'Ivoire | Tablet | 1 | $0.341 | $0.341 | Small sample / trial shipment |
| Dec 2025 | RMPL PHARMA LLP | Turkey | Tablet | 30 | $13.78 | $0.459 | Small sample / trial shipment |
| Dec 2025 | AMARI TRADE ALLI… | Turkey | Tablet | 20 | $9.42 | $0.471 | Small sample / trial shipment |
| Dec 2025 | HEET HEALTHCARE … | Azerbaijan | Tablet | 3 | $1.44 | $0.481 | Small sample / trial shipment |
§7.3 Procurement cheat sheet — median USD/unit by country × dosage
Fig 7.2 Median unit price by country × dosage form — darker cells = higher prices.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each cell shows the median price per unit for that country-dosage combination. Dark blue = expensive, light = cheap. Blank cells = no shipments in that combination.
NEGOTIATION RANGE
Use each cell value as the anchor price. Typical dynamics:
- Budget buyer: anchor − 10–15% (floor = cost + freight)
- Mid-market: anchor ± 5–10%
- Premium/tender: anchor + 10–25% (regulated, quality premium)
- Injection/infusion: always 4–10× the tablet price
KEY TAKEAWAYS
- Dosage form is the #1 price driver, not destination
- Light cells = easy-entry markets for small suppliers
- Dark cells = premium markets requiring regulatory investment
08
PART IV — MARKET BEHAVIOR
Shipping Ports & Trade Routes
Which Indian ports ship everolimus, which global ports receive it, and which corridors are high-value vs bulk
KEY TAKEAWAY
Everolimus leaves India through 9+ ports. The top 5 (NHAVA SHEVA SEA (JNPT), HYDERABAD AIR, DELHI AIR) handle 95.9% of total USD. SEA moves 25% of shipments.
S FOR SUPPLIERS
Use the dumbbell to classify your port as high-value hub or bulk workhorse. Note the short-sea routes — Bangladesh, Sri Lanka, Myanmar and East Africa are the easiest logistics corridors for first-time exporters.
B FOR BUYERS
Use the destination port ranking to find which Indian ports serve your market. The lead-time estimates tell you what transit time to expect.
Fig 8.1 NHAVA SHEVA SEA (JNPT) handles $1.3M — top 9 Indian origin ports by trade value.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each bar = one Indian port. Bar length = USD value. The largest ports handle the majority of trade.
Fig 8.2 Fairdale is the #1 global destination port — top 25 by USD value.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each bar = one destination port worldwide. Bar length = USD value received from India.
§8.1 Reference transit times for key India → global corridors
| Route | Mode | Transit time | Notes |
|---|---|---|---|
| NHAVA SHEVA SEA (JNPT) → US East Coast | Sea | 22–28 days | Via Suez; 2–3 transshipments typical |
| NHAVA SHEVA SEA (JNPT) → Lagos (Nigeria) | Sea | 18–24 days | Direct liner service available |
| MUMBAI AIR (SAHAR) → New York JFK | Air | 3–5 days | Direct cargo; cold-chain available |
| MUNDRA SEA → Rotterdam | Sea | 20–26 days | Via Suez; Hamburg also served |
| HYDERABAD AIR → London Heathrow | Air | 2–4 days | Pharma-grade cargo corridor |
| CHENNAI SEA → Chittagong (Bangladesh) | Sea | 7–12 days | Short-sea route; high frequency |
| RAXAUL → Birgunj (Nepal) | Road | 1–2 days | Land border crossing |
| NHAVA SHEVA SEA (JNPT) → Mombasa (Kenya) | Sea | 14–20 days | Direct or via Colombo hub |
Table 8.1 — Reference times based on standard shipping corridors. Air = 2–5 days; sea = 7–28 days; road = 1–2 days. Add 3–7 days for customs clearance at destination.
08
PART IV — MARKET BEHAVIOR
Shipping Ports & Trade Routes
Trade corridors — origin port to mode of transport to destination region
KEY TAKEAWAY
SEA dominates at 25% of shipments. The alluvial traces every dollar from Indian origin port through transport mode to destination region.
SEA
$1.6M
59.4% of USD · 24.6% of ships
AIR
$1.1M
40.6% of USD · 75.4% of ships
Fig 8.3 The dominant corridor is NHAVA SHEVA SEA (JNPT) → Sea → N. America ($1.3M).
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Left = Indian origin ports. Middle = transport mode. Right = destination region. Ribbon thickness = USD value; color = mode. Follow the thickest ribbons to find the highest-value corridors.
09
PART V — ACTION
Strategic Opportunities & Action Plan
Market concentration, supply-chain risk, and the dependency patterns that signal where to act
KEY TAKEAWAY
United Arab Emirates is the most concentrated destination (HHI 10000, 2 suppliers). Turkey is the most competitive (HHI 5177).
S FOR SUPPLIERS
The HHI barbell shows where competitors have locked up a market (concentrated = poaching opportunity) vs where you must compete on quality (fragmented). The slope chart reveals who is gaining ground.
B FOR BUYERS
The HHI barbell tells you whether your country has enough supplier options. If concentrated (red zone), you have fewer alternatives.
Fig 9.1 United Arab Emirates (HHI 10,000) is the most concentrated — Turkey (HHI 5,177) is the most competitive.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
What is HHI? The Herfindahl-Hirschman Index measures how concentrated a market is among its suppliers. It ranges from 0 to 10,000. Below 1,500 (green zone) = many suppliers compete openly — healthy, competitive market with low risk. 1,500–2,500 (yellow zone) = a few suppliers hold significant share — moderate concentration. Above 2,500 (red zone) = one or two suppliers dominate the market — high risk for buyers who may lose supply, and hard to break into for new suppliers. Conclusion: 20 of 20 destination markets are concentrated (red zone). 0 are competitive (green zone). Buyers in red-zone markets should urgently qualify a second Indian supplier to reduce dependency risk.
§9.1 Single-source dependencies
| Buyer | Country | Sole supplier | USD | Ships | Risk |
|---|---|---|---|---|---|
| ASCEND LABORATORIES … | United States | ALKEM LABORATORI… | $1.3M | 8 | CRITICAL |
| PHARMACARE PREMIUM | Malta | NATCO PHARMA LTD | $478K | 3 | HIGH |
| UPS SUPPLY CHAIN SOL… | United States | PAR FORMULATIONS… | $279K | 5 | HIGH |
| BRECKENRIDGE PHARMAC… | United States | NATCO PHARMA LTD | $186K | 3 | HIGH |
| NATCO PHARMA (CANADA… | Canada | NATCO PHARMA LTD | $72K | 3 | MEDIUM |
| UPS SUPPLY CHAIN SOL… | United States | PAR FORMULATIONS… | $56K | 1 | MEDIUM |
| SAUDI AMAROX FOR IND… | Saudi Arabia | ASPIRO PHARMA LTD | $11K | 1 | MEDIUM |
| AM BIOTECH PVT LTD | Nepal | BDR PHARMACEUTIC… | $8K | 2 | MEDIUM |
Conclusion: 20 buyers depend on exactly one Indian supplier, representing $2.4M in trade. 1 are rated CRITICAL — if their sole supplier fails, they have no backup. For suppliers: each row is a competitor’s locked-in customer you can target.
§9.2 Multi-source resilience
| Buyer | Country | Suppliers | USD | Dominant | Resilience |
|---|
Conclusion: 0 of these buyers have HIGH resilience (3+ active suppliers). These are the hardest accounts to win but safest partners for long-term contracts.
09
PART V — ACTION
Strategic Opportunities & Action Plan
Market entry playbook and risk landscape by destination country
KEY TAKEAWAY
15 target markets with specific entry approaches. Large suppliers: focus on regulated Tier 1 markets. Small/mid-size: start with Tier 2–3 (low barrier, growing demand).
§9.3 Sourcing recommendations · Table 9.1
| Country | Tier | Lead | Price | Risk | Entry approach |
|---|---|---|---|---|---|
| United States | Tier 3 (emerging) | 3–5 days (air) | $1–$10/unit | LOW | First-mover advantage |
| Malta | Tier 3 (emerging) | 3–5 days (air) | $1–$10/unit | LOW | First-mover advantage |
| Canada | Tier 3 (emerging) | 3–5 days (air) | $1–$10/unit | LOW | First-mover advantage |
| Lebanon | Tier 3 (emerging) | 3–5 days (air) | $1–$10/unit | LOW | First-mover advantage |
| Saudi Arabia | Tier 3 (emerging) | 3–5 days (air) | $1–$10/unit | LOW | First-mover advantage |
| Nepal | Tier 3 (emerging) | 3–5 days (air) | $1–$10/unit | LOW | First-mover advantage |
| Kenya | Tier 3 (emerging) | 3–5 days (air) | $1–$10/unit | LOW | First-mover advantage |
| Iraq | Tier 3 (emerging) | 3–5 days (air) | $1–$10/unit | LOW | First-mover advantage |
| Maldives | Tier 3 (emerging) | 3–5 days (air) | $0.10–$1/unit | LOW | First-mover advantage |
| Uganda | Tier 3 (emerging) | 3–5 days (air) | $1–$10/unit | LOW | First-mover advantage |
| United Arab Emirates | Tier 3 (emerging) | 3–5 days (air) | $1–$10/unit | LOW | First-mover advantage |
| Laos | Tier 3 (emerging) | 3–5 days (air) | $1–$10/unit | LOW | First-mover advantage |
| Chile | Tier 3 (emerging) | 3–5 days (air) | $1–$10/unit | LOW | First-mover advantage |
| Mexico | Tier 3 (emerging) | 3–5 days (air) | $1–$10/unit | LOW | First-mover advantage |
| Brazil | Tier 3 (emerging) | 3–5 days (air) | $1–$10/unit | LOW | First-mover advantage |
For suppliers: Tier 1 markets (US, UK, France) require regulatory investment but offer premium pricing. Tier 3 markets (emerging) have low barriers — ideal for first-time exporters. For buyers: Use the price band and lead time to benchmark your current supplier’s terms.
Fig 9.2 0 markets in the Growth Opportunity zone (competitive + growing). 14 in Fragile Dependency (concentrated + shrinking).
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each bubble = one destination. X-axis = HHI (concentration). Y-axis = growth %. Bubble size = USD. Green zone (top-left) = Growth Opportunity — competitive markets that are growing, best for new entrants. Red zone (bottom-right) = Fragile Dependency — concentrated + shrinking, high supply-chain risk. Conclusion: Key markets are the top growth opportunities.
09
PART V — ACTION
Action Plan & Easy-Entry Markets
12 prioritised actions + 15 low-competition destination countries for small & mid-size suppliers
KEY TAKEAWAY
Quick Wins: execute this quarter. Big Bets: plan for next 6–12 months. Plus 15 countries with ≤5 Indian suppliers — the best entry points for SMEs.
S
FOR SUPPLIERS
| ID | Action | Timing | Impact |
|---|---|---|---|
| A1 | Pitch top single-source buyer in United States | This Q | HIGH |
| A2 | Offer alternative to top multi-source buyer | This Q | HIGH |
| A3 | Audit United Arab Emirates lock-ins (HHI 10000) | This Q | MED |
| A5 | Enter United States (4 suppliers) | This Q | HIGH |
| A6 | Enter Malta (1 suppliers) | This Q | MED |
| A8 | Build Malta distribution | 6–12m | HIGH |
| A9 | Bundle injection/infusion catalog for premium markets | 6–12m | MED |
B
FOR BUYERS
| ID | Action | Timing | Impact |
|---|---|---|---|
| A4 | Monitor rising exporters (climbers) | This Q | MED |
| A7 | Register for United States tenders | 6–12m | HIGH |
| A10 | Track quarterly HHI shifts across key destinations | This Q | LOW |
| A11 | Map competitor buyer portfolios quarterly | This Q | MED |
| A12 | Qualify second source for single-source buyers | This Q | MED |
§9.4 Easy-entry markets — 15 countries with ≤5 Indian suppliers
| # | Country | Region | Suppliers | Q4 USD | Growth | Barrier | Why this is easy |
|---|---|---|---|---|---|---|---|
| 1 | United States | Other | 4 | $2.1M | -40.3% | LOW | Low competition (4 suppliers), accessible market |
| 2 | Malta | Other | 1 | $478K | -100% | LOW | Only 1 Indian suppliers — near-monopoly, easy second-source entry |
| 3 | Canada | Other | 1 | $72K | -100% | LOW | Only 1 Indian suppliers — near-monopoly, easy second-source entry |
| 4 | Lebanon | Other | 2 | $37K | 0% | LOW | Only 2 Indian suppliers — near-monopoly, easy second-source entry |
| 5 | Saudi Arabia | Other | 1 | $11K | -100% | LOW | Only 1 Indian suppliers — near-monopoly, easy second-source entry |
| 6 | Nepal | Asia | 1 | $8K | 0% | LOW | Only 1 Indian suppliers — near-monopoly, easy second-source entry |
| 7 | Kenya | Africa | 2 | $5K | 0% | LOW | Only 2 Indian suppliers — near-monopoly, easy second-source entry |
| 8 | Maldives | Asia | 2 | $1K | +53% | LOW | Only 2 Indian suppliers — near-monopoly, easy second-source entry |
| 9 | Iraq | Other | 1 | $2K | 0% | LOW | Only 1 Indian suppliers — near-monopoly, easy second-source entry |
| 10 | Uganda | Africa | 1 | $1K | 0% | LOW | Only 1 Indian suppliers — near-monopoly, easy second-source entry |
| 11 | United Arab Emirates | Other | 2 | $870 | 0% | LOW | Only 2 Indian suppliers — near-monopoly, easy second-source entry |
| 12 | Laos | Asia | 1 | $845 | 0% | LOW | Only 1 Indian suppliers — near-monopoly, easy second-source entry |
| 13 | Chile | Other | 1 | $744 | 0% | LOW | Only 1 Indian suppliers — near-monopoly, easy second-source entry |
| 14 | Mexico | Other | 1 | $714 | 0% | LOW | Only 1 Indian suppliers — near-monopoly, easy second-source entry |
| 15 | Brazil | Other | 1 | $423 | 0% | LOW | Only 1 Indian suppliers — near-monopoly, easy second-source entry |
This report covers 61 2025-Q4 Everolimus shipments.
TransData Nexus tracks 3.37M+ shipments across all pharmaceuticals since 2020.
→ transdatanexus.com/pharmaceutical/everolimus
10
PART VI — EVIDENCE REGISTER
Comprehensive Shipment Records by Region
Authoritative source behind all analytics in this report — every shipment appears exactly once
KEY TAKEAWAY
This section contains every one of the 61 2025-Q4 everolimus shipments, organised by Region → Exporter → Shipment rows. No row is duplicated.
S FOR SUPPLIERS
Jump to any destination country to see exactly who your competitors ship to, what they charge, through which port, and how often.
B FOR BUYERS
Jump to your country to see every Indian everolimus shipment that arrived in 2025-Q4: supplier, price, dosage, port.
§10.1 Global totals
SHIPMENTS
61
across all regions
TOTAL USD
$2.70M
2025-Q4 FOB value
UNITS
227.8K
tablets, capsules, etc.
SUPPLIERS
23
Indian exporters
BUYERS
22
global importers
COUNTRIES
20
destinations
§10.2 Regional breakdown
§10.3 Key insights from the data
Africa is the largest region at $6K (0.2%), spanning 5 countries.
23 Indian suppliers shipped to 22 buyers across 20 countries — average shipment value $44K.
Top 0 markets: .
Every row below is real customs data — date, importer, dosage, brand, quantity, unit price, total USD, origin port, destination port, and transport mode.
§10.4 How to read a country page
1
6 KPI cards — shipments, USD, qty, exporters, importers, avg unit price.
2
4 mini-lists — top exporters, importers, dosages, monthly trend.
3
Shipment register — every row grouped by exporter. No row is duplicated or omitted.
10
PART VI — DRILL-DOWN · AFRICA
Region: Africa
5 countries · 10 shipments · $6K · 6 Indian suppliers · 4 buyers
SHIPMENTS
10
USD
$6K
COUNTRIES
5
SUPPLIERS
6
BUYERS
4
HHI
5,475
concentrated
Top 5 destination countries in Africa
1
Kenya (77.4%)
$5K
2
Uganda (22.4%)
$1K
3
Tanzania (0.1%)
$7.02
4
Seychelles (0.1%)
$3.24
5
Cote d'Ivoire (0.0%)
$0.341
Top 6 Indian suppliers into Africa
1
R.S. SURGIPHARM PVT LTD
$4K
2
BDR PHARMACEUTICALS INTERNATIONAL PVT LTD
$1K
3
3S CORP
$461.36
4
RMPL PHARMA LLP
$7.02
5
CHOUDHARI IMPEX
$3.24
6
BRUCK PHARMA PVT LTD
$0.341
Top 2 Africa importers
1
ONLT · Uganda
$1K
2
FOR .THE ORDER OF · Kenya
$461.36
Top 1 dosage forms
1
Tablet
$6K
Monthly trend
| Month | Ships | USD | Avg/ship |
|---|---|---|---|
| Oct | 0 | $0.0000 | — |
| Nov | 2 | $2K | $933.86 |
| Dec | 8 | $4K | $559.37 |
Shipment register · 10 rows · grouped by exporter
| # | Date | Importer | Country | Dosage | Qty | Unit | Unit $ | Total $ | Origin | Dest | Mode |
|---|---|---|---|---|---|---|---|---|---|---|---|
| SUPPLIER #1 — R.S. SURGIPHARM PVT LTD · 4 shipments · $4K | |||||||||||
| 1 | Dec 2025 | UNKNOWN BUYER | Kenya | Tablet | 20 | PCS | $59.82 | $1K | MUMBAI AIR (SAHAR) | NAIROBI | AIR |
| 2 | Dec 2025 | UNKNOWN BUYER | Kenya | Tablet | 15 | PCS | $8.42 | $126.36 | MUMBAI AIR (SAHAR) | NAIROBI | AIR |
| 3 | Dec 2025 | UNKNOWN BUYER | Kenya | Tablet | 105 | PCS | $8.42 | $884.56 | MUMBAI AIR (SAHAR) | NAIROBI | AIR |
| 4 | Dec 2025 | UNKNOWN BUYER | Kenya | Tablet | 60 | PCS | $37.35 | $2K | MUMBAI AIR (SAHAR) | NAIROBI | AIR |
| SUPPLIER #2 — BDR PHARMACEUTICALS INTERNATIONAL PVT LTD · 2 shipments · $1K | |||||||||||
| 5 | Nov 2025 | ONLT | Uganda | Tablet | 20 | NOS | $70.32 | $1K | MUMBAI AIR (SAHAR) | ENTEBBE | AIR |
| 6 | Dec 2025 | ONLT | Uganda | Tablet | 20 | NOS | $0.802 | $16.04 | MUMBAI AIR (SAHAR) | ENTEBBE | AIR |
| SUPPLIER #3 — 3S CORP · 1 shipments · $461.36 | |||||||||||
| 7 | Nov 2025 | FOR .THE ORDER OF | Kenya | Tablet | 10 | NOS | $46.14 | $461.36 | MUMBAI AIR (SAHAR) | NAIROBI | AIR |
| SUPPLIER #4 — RMPL PHARMA LLP · 1 shipments · $7.02 | |||||||||||
| 8 | Dec 2025 | UNLISTED BUYER | Tanzania | Tablet | 200 | NOS | $0.035 | $7.02 | MUMBAI AIR (SAHAR) | DAR ES SALAM (DARESS | AIR |
| SUPPLIER #5 — CHOUDHARI IMPEX · 1 shipments · $3.24 | |||||||||||
| 9 | Dec 2025 | UNLISTED BUYER | Seychelles | Tablet | 2.1K | NOS | $0.0016 | $3.24 | CHENNAI AIR | MAHE ISLAND | AIR |
| SUPPLIER #6 — BRUCK PHARMA PVT LTD · 1 shipments · $0.341 | |||||||||||
| 10 | Dec 2025 | UNLISTED BUYER | Cote d'Ivoire | Tablet | 1 | NOS | $0.341 | $0.341 | MUMBAI AIR (SAHAR) | ABIDJAN | AIR |
10
PART VI — DRILL-DOWN · ASIA
Region: Asia
9 countries · 20 shipments · $61K · 12 Indian suppliers · 11 buyers
SHIPMENTS
20
USD
$61K
COUNTRIES
9
SUPPLIERS
12
BUYERS
11
HHI
3,658
concentrated
Top 9 destination countries in Asia
1
Lebanon (60.2%)
$37K
2
Saudi Arabia (18.7%)
$11K
3
Nepal (12.9%)
$8K
4
Iraq (3.0%)
$2K
5
Maldives (2.4%)
$1K
6
United Arab Emirates (1.4%)
$870.18
7
Laos (1.4%)
$845.47
8
Turkey (0.0%)
$23.19
9
Azerbaijan (0.0%)
$1.44
Top 12 Indian suppliers into Asia
1
GLOBELA PHARMA PVT LTD
$34K
2
ASPIRO PHARMA LTD
$11K
3
BDR PHARMACEUTICALS INTERNATIONAL PVT LTD
$8K
4
RMPL PHARMA LLP
$3K
5
VATS INDUSTRIES PVT LTD
$2K
6
NU HOSPITALS PVT LTD
$1K
7
SEATRACK INTERNATIONAL TRADEX PVT LTD
$870.18
8
KASO PHARMACEUTICALS
$845.47
9
AMARI TRADE ALLIANCE LLP
$9.42
10
MC PHARMA DISTRIBUTORS
$3.13
11
HEET HEALTHCARE PVT LTD
$1.44
12
MARKSANS PHARMA LTD
$0.0000
Top 10 Asia importers
1
SAUDI AMAROX FOR INDUSTRY COMPANY · Saudi Arabia
$11K
2
AM BIOTECH PVT LTD · Nepal
$8K
3
ATLAS TRADING COMPANY · Iraq
$2K
4
INDIRA GANDHI MEMOROAL HOSPITAL · Maldives
$1K
5
ZMC EXPRESS CARGO FZCO · United Arab Emirates
$870.18
6
MR VONMUNA · Laos
$845.47
7
ABU ABDU · Turkey
$9.42
8
STATE TRADING ORGANIZATION PLC · Maldives
$3.13
9
NAME : AYGUN · Azerbaijan
$1.44
10
AL KHALLEJ LAND HOLDING FZCO · United Arab Emirates
$0.0000
Top 2 dosage forms
1
Tablet
$60K
2
Unknown
$845.47
Monthly trend
| Month | Ships | USD | Avg/ship |
|---|---|---|---|
| Oct | 3 | $12K | $4K |
| Nov | 2 | $5K | $2K |
| Dec | 15 | $44K | $3K |
Shipment register · 20 rows · grouped by exporter
| # | Date | Importer | Country | Dosage | Qty | Unit | Unit $ | Total $ | Origin | Dest | Mode |
|---|---|---|---|---|---|---|---|---|---|---|---|
| SUPPLIER #1 — GLOBELA PHARMA PVT LTD · 1 shipments · $34K | |||||||||||
| 1 | Dec 2025 | UNLISTED BUYER | Lebanon | Tablet | 334 | NOS | $102.00 | $34K | MUMBAI AIR (SAHAR) | BEIRUT | AIR |
| SUPPLIER #2 — ASPIRO PHARMA LTD · 1 shipments · $11K | |||||||||||
| 2 | Oct 2025 | SAUDI AMAROX FOR INDUSTRY COMPANY | Saudi Arabia | Tablet | 5.0K | NOS | $2.27 | $11K | HYDERABAD AIR | JEDDAH | AIR |
| SUPPLIER #3 — BDR PHARMACEUTICALS INTERNATIONAL PVT LTD · 2 shipments · $8K | |||||||||||
| 3 | Nov 2025 | AM BIOTECH PVT LTD | Nepal | Tablet | 100 | NOS | $39.47 | $4K | MUMBAI AIR (SAHAR) | KATHMANDU - TRIBHUVA | AIR |
| 4 | Dec 2025 | AM BIOTECH PVT LTD | Nepal | Tablet | 100 | NOS | $39.51 | $4K | MUMBAI AIR (SAHAR) | KATHMANDU - TRIBHUVA | AIR |
| SUPPLIER #4 — RMPL PHARMA LLP · 2 shipments · $3K | |||||||||||
| 5 | Dec 2025 | UNLISTED BUYER | Lebanon | Tablet | 50 | NOS | $54.60 | $3K | MUMBAI AIR (SAHAR) | BEIRUT | AIR |
| 6 | Dec 2025 | UNLISTED BUYER | Turkey | Tablet | 30 | NOS | $0.459 | $13.78 | MUMBAI AIR (SAHAR) | ADANA | AIR |
| SUPPLIER #5 — VATS INDUSTRIES PVT LTD · 3 shipments · $2K | |||||||||||
| 7 | Dec 2025 | ATLAS TRADING COMPANY | Iraq | Tablet | 20 | NOS | $45.33 | $906.60 | DELHI AIR | BAGDAD, METROPOLITAN | AIR |
| 8 | Dec 2025 | ATLAS TRADING COMPANY | Iraq | Tablet | 1 | NOS | $45.33 | $45.33 | DELHI AIR | BAGDAD, METROPOLITAN | AIR |
| 9 | Dec 2025 | ATLAS TRADING COMPANY | Iraq | Tablet | 19 | NOS | $45.44 | $863.44 | DELHI AIR | BAGDAD, METROPOLITAN | AIR |
| SUPPLIER #6 — NU HOSPITALS PVT LTD · 4 shipments · $1K | |||||||||||
| 10 | Oct 2025 | INDIRA GANDHI MEMOROAL HOSPITAL | Maldives | Tablet | 360 | NOS | $1.61 | $579.02 | BANGALORE AIR | MALE | AIR |
| 11 | Dec 2025 | INDIRA GANDHI MEMOROAL HOSPITAL | Maldives | Tablet | 540 | NOS | $1.62 | $876.10 | BANGALORE AIR | MALE | AIR |
| 12 | Dec 2025 | INDIRA GANDHI MEMOROAL HOSPITAL | Maldives | Tablet | 60 | NOS | $0.018 | $1.11 | BANGALORE AIR | MALE | AIR |
| 13 | Dec 2025 | INDIRA GANDHI MEMOROAL HOSPITAL | Maldives | Tablet | 300 | NOS | $0.018 | $5.53 | BANGALORE AIR | MALE | AIR |
| SUPPLIER #7 — SEATRACK INTERNATIONAL TRADEX PVT LTD · 2 shipments · $870.18 | |||||||||||
| 14 | Dec 2025 | ZMC EXPRESS CARGO FZCO | United Arab Emirates | Tablet | 15 | NOS | $41.44 | $621.56 | DELHI AIR | DUBAI | AIR |
| 15 | Dec 2025 | ZMC EXPRESS CARGO FZCO | United Arab Emirates | Tablet | 6 | NOS | $41.44 | $248.62 | DELHI AIR | DUBAI | AIR |
| SUPPLIER #8 — KASO PHARMACEUTICALS · 1 shipments · $845.47 | |||||||||||
| 16 | Nov 2025 | MR VONMUNA | Laos | 19 | NOS | $44.50 | $845.47 | DELHI AIR | VIENTIANE | AIR | |
| SUPPLIER #9 — AMARI TRADE ALLIANCE LLP · 1 shipments · $9.42 | |||||||||||
| 17 | Dec 2025 | ABU ABDU | Turkey | Tablet | 20 | NOS | $0.471 | $9.42 | MUMBAI AIR (SAHAR) | ADANA | AIR |
| SUPPLIER #10 — MC PHARMA DISTRIBUTORS · 1 shipments · $3.13 | |||||||||||
| 18 | Dec 2025 | STATE TRADING ORGANIZATION PLC | Maldives | Tablet | 360 | PCS | $0.0087 | $3.13 | CHENNAI AIR | MALE | AIR |
| SUPPLIER #11 — HEET HEALTHCARE PVT LTD · 1 shipments · $1.44 | |||||||||||
| 19 | Dec 2025 | NAME : AYGUN | Azerbaijan | Tablet | 3 | NOS | $0.481 | $1.44 | MUMBAI AIR (SAHAR) | BAKU | AIR |
| SUPPLIER #12 — MARKSANS PHARMA LTD · 1 shipments · $0.0000 | |||||||||||
| 20 | Oct 2025 | AL KHALLEJ LAND HOLDING FZCO | United Arab Emirates | Tablet | 1 | NOS | $0.0000 | $0.0000 | NHAVA SHEVA SEA (JNPT) | Jebel Ali | SEA |
10
PART VI — DRILL-DOWN · EUROPE
Region: Europe
1 countries · 3 shipments · $478K · 1 Indian suppliers · 1 buyers
SHIPMENTS
3
USD
$478K
COUNTRIES
1
SUPPLIERS
1
BUYERS
1
HHI
10,000
concentrated
Top 1 destination countries in Europe
1
Malta (100.0%)
$478K
Top 1 Indian suppliers into Europe
1
NATCO PHARMA LTD
$478K
Top 1 Europe importers
1
PHARMACARE PREMIUM · Malta
$478K
Top 1 dosage forms
1
Tablet
$478K
Monthly trend
| Month | Ships | USD | Avg/ship |
|---|---|---|---|
| Oct | 3 | $478K | $159K |
| Nov | 0 | $0.0000 | — |
| Dec | 0 | $0.0000 | — |
Shipment register · 3 rows · grouped by exporter
| # | Date | Importer | Country | Dosage | Qty | Unit | Unit $ | Total $ | Origin | Dest | Mode |
|---|---|---|---|---|---|---|---|---|---|---|---|
| SUPPLIER #1 — NATCO PHARMA LTD · 3 shipments · $478K | |||||||||||
| 1 | Oct 2025 | PHARMACARE PREMIUM | Malta | Tablet | 34.2K | NOS | $7.61 | $260K | HYDERABAD AIR | MALTA | AIR |
| 2 | Oct 2025 | PHARMACARE PREMIUM | Malta | Tablet | 47.9K | NOS | $4.10 | $196K | HYDERABAD AIR | MALTA | AIR |
| 3 | Oct 2025 | PHARMACARE PREMIUM | Malta | Tablet | 7.2K | NOS | $3.04 | $22K | HYDERABAD AIR | MALTA | AIR |
10
PART VI — DRILL-DOWN · AMERICAS
Region: Americas
5 countries · 28 shipments · $2.16M · 7 Indian suppliers · 9 buyers
SHIPMENTS
28
USD
$2.16M
COUNTRIES
5
SUPPLIERS
7
BUYERS
9
HHI
5,609
concentrated
Top 5 destination countries in Americas
1
United States (96.6%)
$2.08M
2
Canada (3.4%)
$72K
3
Chile (0.0%)
$744.46
4
Mexico (0.0%)
$713.90
5
Brazil (0.0%)
$423.27
Top 7 Indian suppliers into Americas
1
ALKEM LABORATORIES LTD
$1.56M
2
PAR FORMULATIONS PVT LTD
$336K
3
NATCO PHARMA LTD
$259K
4
ALLMPUS LABORATORIES PVT LTD
$1K
5
KALINDI OVERSEAS
$744.46
6
MEDINEX HEALTHCARE
$713.90
7
YARAPMIN PHARMA PVT LTD
$423.27
Top 7 Americas importers
1
ASCEND LABORATORIES LLC · United States
$1.27M
2
UPS SUPPLY CHAIN SOLUTION INC · United States
$279K
3
BRECKENRIDGE PHARMACEUTICAL INC · United States
$186K
4
NATCO PHARMA (CANADA) INC · Canada
$72K
5
UPS SUPPLY CHAIN SOLUTIONS INC · United States
$56K
6
UNITED AMERICA GROUP LLC · United States
$1K
7
THE PURCHASE MANAGER · Chile
$744.46
Top 3 dosage forms
1
Tablet
$2.15M
2
Injection
$1K
3
Unknown
$423.27
Monthly trend
| Month | Ships | USD | Avg/ship |
|---|---|---|---|
| Oct | 13 | $989K | $76K |
| Nov | 7 | $617K | $88K |
| Dec | 8 | $549K | $69K |
Shipment register · 28 rows · grouped by exporter
| # | Date | Importer | Country | Dosage | Qty | Unit | Unit $ | Total $ | Origin | Dest | Mode |
|---|---|---|---|---|---|---|---|---|---|---|---|
| SUPPLIER #1 — ALKEM LABORATORIES LTD · 10 shipments · $1.56M | |||||||||||
| 1 | Oct 2025 | ASCEND LABORATORIES LLC | United States | Tablet | 2.1K | NOS | $67.55 | $143K | NHAVA SHEVA SEA (JNPT) | Fairdale | SEA |
| 2 | Oct 2025 | ASCEND LABORATORIES LLC | United States | Tablet | 2.1K | NOS | $49.94 | $104K | NHAVA SHEVA SEA (JNPT) | Fairdale | SEA |
| 3 | Oct 2025 | ASCEND LABORATORIES LLC | United States | Tablet | 3.0K | NOS | $48.57 | $146K | NHAVA SHEVA SEA (JNPT) | Fairdale | SEA |
| 4 | Oct 2025 | ASCEND LABORATORIES LLC | United States | Tablet | 3.3K | NOS | $49.56 | $164K | NHAVA SHEVA SEA (JNPT) | Fairdale | SEA |
| 5 | Nov 2025 | ASCEND LABORATORIES LLC | United States | Tablet | 3.4K | NOS | $49.92 | $169K | NHAVA SHEVA SEA (JNPT) | Newark | SEA |
| 6 | Nov 2025 | UNKNOWN BUYER | United States | Tablet | 3.4K | NOS | $49.92 | $169K | NHAVA SHEVA SEA (JNPT) | Newark | SEA |
| 7 | Nov 2025 | UNKNOWN BUYER | United States | Tablet | 1.1K | NOS | $103.97 | $115K | NHAVA SHEVA SEA (JNPT) | Newark | SEA |
| 8 | Dec 2025 | ASCEND LABORATORIES LLC | United States | Tablet | 2.2K | NOS | $69.30 | $152K | NHAVA SHEVA SEA (JNPT) | Newark Apt/New York | SEA |
| 9 | Dec 2025 | ASCEND LABORATORIES LLC | United States | Tablet | 2.3K | NOS | $102.97 | $232K | DELHI AIR | WASHINGTON, DULLES I | AIR |
| 10 | Dec 2025 | ASCEND LABORATORIES LLC | United States | Tablet | 3.2K | NOS | $50.83 | $162K | NHAVA SHEVA SEA (JNPT) | Newark Apt/New York | SEA |
| SUPPLIER #2 — PAR FORMULATIONS PVT LTD · 6 shipments · $336K | |||||||||||
| 11 | Oct 2025 | UPS SUPPLY CHAIN SOLUTIONS INC | United States | Tablet | 1.7K | NOS | $33.90 | $56K | BANGALORE AIR | ATLANTA, HARTSFIELD | AIR |
| 12 | Oct 2025 | UPS SUPPLY CHAIN SOLUTION INC | United States | Tablet | 1.7K | NOS | $33.90 | $59K | ENNORE SEA | SAVANNAH | SEA |
| 13 | Oct 2025 | UPS SUPPLY CHAIN SOLUTION INC | United States | Tablet | 1.7K | NOS | $33.90 | $58K | ENNORE SEA | SAVANNAH | SEA |
| 14 | Nov 2025 | UPS SUPPLY CHAIN SOLUTION INC | United States | Tablet | 296 | NOS | $21.62 | $6K | KAMARAJAR PORT SEA | Savannah | SEA |
| 15 | Nov 2025 | UPS SUPPLY CHAIN SOLUTION INC | United States | Tablet | 3.6K | NOS | $21.62 | $77K | KAMARAJAR PORT SEA | Savannah | SEA |
| 16 | Nov 2025 | UPS SUPPLY CHAIN SOLUTION INC | United States | Tablet | 3.7K | NOS | $21.62 | $79K | KAMARAJAR PORT SEA | Savannah | SEA |
| SUPPLIER #3 — NATCO PHARMA LTD · 6 shipments · $259K | |||||||||||
| 17 | Oct 2025 | BRECKENRIDGE PHARMACEUTICAL INC | United States | Tablet | 33.8K | NOS | $4.51 | $152K | HYDERABAD AIR | CHICAGO O'HARE INT'L | AIR |
| 18 | Oct 2025 | BRECKENRIDGE PHARMACEUTICAL INC | United States | Tablet | 16.5K | NOS | $1.20 | $20K | HYDERABAD AIR | CHICAGO O'HARE INT'L | AIR |
| 19 | Oct 2025 | BRECKENRIDGE PHARMACEUTICAL INC | United States | Tablet | 13.2K | NOS | $1.10 | $15K | HYDERABAD AIR | CHICAGO O'HARE INT'L | AIR |
| 20 | Oct 2025 | NATCO PHARMA (CANADA) INC | Canada | Tablet | 9.7K | NOS | $1.38 | $13K | HYDERABAD AIR | Toronto | AIR |
| 21 | Oct 2025 | NATCO PHARMA (CANADA) INC | Canada | Tablet | 8.4K | NOS | $2.52 | $21K | HYDERABAD AIR | Toronto | AIR |
| 22 | Oct 2025 | NATCO PHARMA (CANADA) INC | Canada | Tablet | 8.2K | NOS | $4.59 | $38K | HYDERABAD AIR | Toronto | AIR |
| SUPPLIER #4 — ALLMPUS LABORATORIES PVT LTD · 2 shipments · $1K | |||||||||||
| 23 | Dec 2025 | UNITED AMERICA GROUP LLC | United States | Injection | 1 | SET | $177.06 | $177.06 | MUMBAI AIR (SAHAR) | NEW YORK | AIR |
| 24 | Dec 2025 | UNITED AMERICA GROUP LLC | United States | Injection | 1 | SET | $1K | $1K | MUMBAI AIR (SAHAR) | NEW YORK | AIR |
| SUPPLIER #5 — KALINDI OVERSEAS · 2 shipments · $744.46 | |||||||||||
| 25 | Nov 2025 | THE PURCHASE MANAGER | Chile | Tablet | 72 | NOS | $10.14 | $730.12 | MUMBAI AIR (SAHAR) | SANTIAGO DE CHILE - | AIR |
| 26 | Dec 2025 | THE PURCHASE MANAGER | Chile | Tablet | 72 | NOS | $0.199 | $14.35 | MUMBAI AIR (SAHAR) | SANTIAGO DE CHILE - | AIR |
| SUPPLIER #6 — MEDINEX HEALTHCARE · 1 shipments · $713.90 | |||||||||||
| 27 | Dec 2025 | UNLISTED BUYER | Mexico | Tablet | 5 | NOS | $142.78 | $713.90 | MUMBAI AIR (SAHAR) | MEXICO CITY | AIR |
| SUPPLIER #7 — YARAPMIN PHARMA PVT LTD · 1 shipments · $423.27 | |||||||||||
| 28 | Dec 2025 | UNLISTED BUYER | Brazil | 6 | NOS | $70.55 | $423.27 | AHMEDABAD AIR | GUARULHOS | AIR | |
10
PART VI — EVIDENCE REGISTER
Indian Supplier Directory
All 23 Indian everolimus exporters — complete list ranked by USD
KEY TAKEAWAY
This directory lists every Indian company that shipped everolimus in 2025-Q4.
S FOR SUPPLIERS
Find yourself and your competitors. Compare shipment count, USD, and destination regions.
B FOR BUYERS
Search for potential Indian suppliers. Filter by dosage form and destination region.
| # | Supplier | City | Ships | USD | Dosage forms | Primary regions |
|---|---|---|---|---|---|---|
| 1 | ALKEM LABORATORIES LTD | LOWER PAREL | 10 | $1.56M | Tablet | Americas |
| 2 | NATCO PHARMA LTD | HYDERABAD | 9 | $737K | Tablet | Americas, Europe |
| 3 | PAR FORMULATIONS PVT LTD | KELAMBAKKAM | 6 | $336K | Tablet | Americas |
| 4 | GLOBELA PHARMA PVT LTD | SURAT | 1 | $34K | Tablet | Asia |
| 5 | ASPIRO PHARMA LTD | Siddipeta District | 1 | $11K | Tablet | Asia |
| 6 | BDR PHARMACEUTICALS INTERNATIONAL PVT LTD | MUMBAI | 4 | $9K | Tablet | Asia, Africa |
| 7 | R.S. SURGIPHARM PVT LTD | AHMEDABAD | 4 | $4K | Tablet | Africa |
| 8 | RMPL PHARMA LLP | MUMBAI | 3 | $3K | Tablet | Asia, Africa |
| 9 | VATS INDUSTRIES PVT LTD | NEW DELHI | 3 | $2K | Tablet | Asia |
| 10 | NU HOSPITALS PVT LTD | BENGALURU | 4 | $1K | Tablet | Asia |
| 11 | ALLMPUS LABORATORIES PVT LTD | AMRAVATI | 2 | $1K | Injection | Americas |
| 12 | SEATRACK INTERNATIONAL TRADEX PVT LTD | NEW DELHI | 2 | $870.18 | Tablet | Asia |
| 13 | KASO PHARMACEUTICALS | NEW DELHI | 1 | $845.47 | Asia | |
| 14 | KALINDI OVERSEAS | MUMBAI | 2 | $744.46 | Tablet | Americas |
| 15 | MEDINEX HEALTHCARE | Mumbai | 1 | $713.90 | Tablet | Americas |
| 16 | 3S CORP | MUMBAI | 1 | $461.36 | Tablet | Africa |
| 17 | YARAPMIN PHARMA PVT LTD | AHMEDABAD | 1 | $423.27 | Americas | |
| 18 | AMARI TRADE ALLIANCE LLP | MUMBAI | 1 | $9.42 | Tablet | Asia |
| 19 | CHOUDHARI IMPEX | CHENNAI | 1 | $3.24 | Tablet | Africa |
| 20 | MC PHARMA DISTRIBUTORS | CHENNAI | 1 | $3.13 | Tablet | Asia |
| 21 | HEET HEALTHCARE PVT LTD | AHMEDABAD | 1 | $1.44 | Tablet | Asia |
| 22 | BRUCK PHARMA PVT LTD | NANI | 1 | $0.341 | Tablet | Africa |
| 23 | MARKSANS PHARMA LTD | MUMBAI | 1 | $0.0000 | Tablet | Asia |
10
PART VI — EVIDENCE REGISTER
Global Buyer Directory
All 20 global everolimus importers — complete list ranked by USD
KEY TAKEAWAY
This directory lists every company that imported Indian everolimus in 2025-Q4.
S FOR SUPPLIERS
Search for potential customers by country and dosage form.
B FOR BUYERS
Find your company and see which Indian supplier serves you.
| # | Buyer | Country | Ships | USD | Primary supplier | Dosage forms |
|---|---|---|---|---|---|---|
| 1 | ASCEND LABORATORIES LLC | United States | 8 | $1.27M | ALKEM LABORATORIES LTD | Tablet |
| 2 | PHARMACARE PREMIUM | Malta | 3 | $478K | NATCO PHARMA LTD | Tablet |
| 3 | UPS SUPPLY CHAIN SOLUTION INC | United States | 5 | $279K | PAR FORMULATIONS PVT… | Tablet |
| 4 | BRECKENRIDGE PHARMACEUTICAL INC | United States | 3 | $186K | NATCO PHARMA LTD | Tablet |
| 5 | NATCO PHARMA (CANADA) INC | Canada | 3 | $72K | NATCO PHARMA LTD | Tablet |
| 6 | UPS SUPPLY CHAIN SOLUTIONS INC | United States | 1 | $56K | PAR FORMULATIONS PVT… | Tablet |
| 7 | SAUDI AMAROX FOR INDUSTRY COMPANY | Saudi Arabia | 1 | $11K | ASPIRO PHARMA LTD | Tablet |
| 8 | AM BIOTECH PVT LTD | Nepal | 2 | $8K | BDR PHARMACEUTICALS … | Tablet |
| 9 | ATLAS TRADING COMPANY | Iraq | 3 | $2K | VATS INDUSTRIES PVT … | Tablet |
| 10 | INDIRA GANDHI MEMOROAL HOSPITAL | Maldives | 4 | $1K | NU HOSPITALS PVT LTD | Tablet |
| 11 | ONLT | Uganda | 2 | $1K | BDR PHARMACEUTICALS … | Tablet |
| 12 | UNITED AMERICA GROUP LLC | United States | 2 | $1K | ALLMPUS LABORATORIES… | Injection |
| 13 | ZMC EXPRESS CARGO FZCO | United Arab Emirates | 2 | $870.18 | SEATRACK INTERNATION… | Tablet |
| 14 | MR VONMUNA | Laos | 1 | $845.47 | KASO PHARMACEUTICALS | |
| 15 | THE PURCHASE MANAGER | Chile | 2 | $744.46 | KALINDI OVERSEAS | Tablet |
| 16 | FOR .THE ORDER OF | Kenya | 1 | $461.36 | 3S CORP | Tablet |
| 17 | ABU ABDU | Turkey | 1 | $9.42 | AMARI TRADE ALLIANCE… | Tablet |
| 18 | STATE TRADING ORGANIZATION PLC | Maldives | 1 | $3.13 | MC PHARMA DISTRIBUTORS | Tablet |
| 19 | NAME : AYGUN | Azerbaijan | 1 | $1.44 | HEET HEALTHCARE PVT … | Tablet |
| 20 | AL KHALLEJ LAND HOLDING FZCO | United Arab Emirates | 1 | $0.0000 | MARKSANS PHARMA LTD | Tablet |
This report covers 61 2025-Q4 Everolimus shipments.
TransData Nexus tracks 3.37M+ shipments across all pharmaceuticals since 2020.
→ transdatanexus.com/pharmaceutical/everolimus
Talk to our trade analyst
Need a custom everolimus report or a deeper dive into any market? Our team is ready.
WhatsApp: +91 95950 78788 · transdatanexus.com
PHARMA TRADE INTELLIGENCE
Thank you for reading
This report is part of the TransData Nexus Pharma Trade Intelligence series, covering 366 pharmaceutical products exported from India.
Every figure is grounded in real commercial trade records — official customs filings and licensed databases. No surveys, no estimates, no fake data.
Need a custom report?
We can generate intelligence for any pharmaceutical product, any time period, any combination of source and destination countries.
Want deeper analysis?
Our team provides competitive intelligence, market entry strategy, and supply chain due diligence for pharma importers and exporters.
Scan for product page
WhatsApp: +91 95950 78788
Email: info@transdatanexus.com
Web: https://transdatanexus.com/pharmaceutical/everolimus
© 2026 TransData Nexus. All rights reserved. This report is provided for informational purposes only.
Data sourced from official customs filings and licensed commercial trade databases.
Reproduction without permission is prohibited.
Explore the full Everolimus product page
Live data, supplier directory, price trends, and trade route analysis